Aileron Therapeutics Inc raised $33,000,000 on , from Aju Ib Investment Co ....

Get alertedif Aileron Therapeutics Inc gets funded!
Amount:$33,000,000
Company:
Investors:, , , , , ,
Industry:Biotechnology
Country:
State:
City:
United States
Massachusetts
Cambridge
Key people:Joseph A. Yanchik Iii (President & CEO)
Yong Chang (Vice President, Biology and Translational Research)
Hubert Chen (Vice President, Clinical Development)
S. Edward Torres (Investor)
Brian Gallagher (Board Member)
Seth L. Harrison (Board Member)
John Mcarthur (Board Member, Director)
Enrico Petrillo (Board Member, Director)
Dr. Reinhard Ambros (Board Member)
Joseph Yanchik Iii (Director, Executive Officer, Executive_Officer)
Data sources:
www.marketwatch.com - Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug - MarketWatch
www.owler.com - Aileron Therapeutics received $33M in Series E Funding http://t.co/vcqnBwRngd
www.vcnewsdaily.com - Aileron Therapeutics Secures $33M in Series E http://t.co/yxEuWNhOxP http://t.co/UPDaOmgwsC
www.biospace.com - MA BioPharma Aileron Therapeutics Locks In A Total Of $48 Million: Aileron Therapeutics Secures $33 Million in... http://t.co/FVMhNHimtX
www.heraldonline.com - CAMBRIDGE, Mass.: Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug | Business Wire | Rock Hill Herald Online
www.pehub.com - PE HUB » Aileron Therapeutics grabs $33 mln Series E
www.vcaonline.com - Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug http://t.co/69EoEKgukY | VCA
www.pharmaceutical-business-review.com - Aileron Therapeutics secures $33m in series E financing to advance cancer drug development: Aileron Therapeuti... http://t.co/wdLZf7usmZ
drugdiscovery.pharmaceutical-business-review.com - New post: "Aileron Therapeutics secures $33m in series E financing to advance cancer drug development" http://t.co/k2wmo1bEYX
cphi-online.com - Aileron Therapeutics Secures $33 Million in Financing, Expands Senior Management Team http://t.co/D8y1OOAnaD
www.businesswire.com - Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug | Business Wire
www.pharmaceutical-business-review.com - Aileron Therapeutics secures $33m in series E financing to advance cancer drug development http://t.co/3cXrCUXch1 #pharma
Description:
In 2014, October 29th, an investment of 33M has been closed by Aileron Therapeutics Inc. Aileron Therapeutics Inc is a Biotechnology-specialized firm.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!